Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion. - Shenderov E; Sharma MR; Garralda E; Powderly J; Ługowska I; Spira A; Salamero MC; Jang S; Cosman R; Shen J; Xu W; Wysocki PJ; et al. (Cancer, 2026)